Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away.
That’s the vision of the field of bioelectronic medicine — the emerging discipline that has made enough promising advances to draw a big investment by a pharmaceutical giant, according to an article in Chemical & Engineering News(C&EN), the weekly news magazine of the American Chemical Society.
Ann M. Thayer, a senior correspondent at C&EN, explains that much of the progress made in bioelectronic medicine has been driven by university research so far. But more than a year ago, the British drug company GlaxoSmithKline dove into the field and is now funding about 25 investigations exploring disease biology and neural signaling. They are betting that the budding discipline will lead to a whole new class of medicines for metabolic, immune-inflammatory, respiratory, cardiovascular and other disorders.
Others are also heavily invested in the future of bioelectronic science. A few start-ups are working toward clinical applications. The National Institutes of Health is also advancing neuroscience with its Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. But scientists still have to work out some major puzzles before they can benefit patients. For one, they have to completely map out which nerves affect which organs and functions. Once that base is built, the field could be well poised to take off.
The Latest on: Bioelectronics
[google_news title=”” keyword=”Bioelectronics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bioelectronics
- A step forward for self-health monitoring—wireless charging through a magnetic connectionon April 30, 2024 at 9:43 am
Zheng Yan and a team of researchers at the University of Missouri have made a significant breakthrough in their ongoing development of an on-skin wearable bioelectronic device. Yan's lab, which ...
- Neurosoft’s Dr Nicholas Vachicouras on the evolution of neurological rehabilitationon April 30, 2024 at 3:01 am
Combining recorded brain data with electrical muscle stimulation could open new doorways for neurorehabilitation.
- Bioplastic “Alive” with Bacterial Spores Can Compost Itselfon April 29, 2024 at 5:00 pm
wearable bioelectronics, drug delivery systems, wound healing patches and self-regenerating skin.” Introducing live cells into polymer composites could significantly improve both their material ...
- What I learnt… from making 65 angel investmentson April 29, 2024 at 3:00 pm
Funding science start-ups that can make a difference in the world may have its own rewards, but you still need to see beyond the ‘shiny stuff’ ...
- Biological Indicator Vial Market Poised for 1.6X Growth by 2034, Fueled by Healthcare Safety Prioritieson April 29, 2024 at 7:43 am
The Biological Indicator Vial Market is poised for significant growth, with its size expected to increase from US$ 163.3 million in 2024 to US$ 265.9 million by 2034. During this period, a modest 5.0% ...
- Science Corporation acquires retinal implant from Pixium Visionon April 26, 2024 at 6:39 am
S cience Corporation, a brain-computer interface technology company, has announced the acquisition of intellectual property and related assets for the Prima retinal implant from French bioelectronics ...
- HKU Mechanical Engineering researchers develop miniaturised electric generators based on hydrogels for use in biomedical deviceson April 25, 2024 at 2:00 pm
The development of engineered devices capable of harvesting the body’s mechanical motion and converting it into electricity is crucial for the functioning of bioelectronics.Mechanoelectrical energy co ...
- The Rise of Natural Polymers: Pioneering Sustainable Material Developmenton April 25, 2024 at 6:42 am
By Taha Khan Apr 25 2024 Reviewed by Lexie Corner Natural polymers are complex molecules composed of long chains of repeating units found in nature. Derived from widely available renewable sources, ...
- Bioelectric Medicine Market Poised to Reach US$ 39.2 Billion by 2031on April 24, 2024 at 3:15 pm
Global Bioelectric Medicine Market was valued at US$ 24.6 billion in 2022 and is projected to hit market revenue of US$ 39.2 billion by 2031 at a CAGR of 6.41% During the Forecast Period 2023-2031.
- Quantum computing, AI, and semiconductor innovationson April 18, 2024 at 8:02 am
In the dynamic landscape of technology, quantum computing and artificial intelligence (AI) emerge as transformative forces, poised to revolutionize industries and reshape investment paradigms.
via Bing News
